Healthcare.gov

Drug manufacturer Amylyx pulls ALS drug Relyvrio from market, citing lack of efficacy

The following is from Public Citizen. Amylyx Pharmaceuticals said on Thursday that it would withdraw AMX0035 (sodium phenylbutyrate and taurursodiol, sold as Relyvrio) from the market. A large clinical trial recently found that the drug did not provide any benefit to patients

Drug manufacturer Amylyx pulls ALS drug Relyvrio from market, citing lack of efficacy Read More »

After Hours: Drs Vaughn and Kory Breaking New Ground on Covid and Covid Vaccine Injuries (Podcast)

The latest must-have information from two cutting edge medical doctors on the front lines of treating thousands of Covid and Covid Vaccine injuries, Dr. Jordan Vaughn and Dr. Pierre Kory. What they’re learning that our own government isn’t telling us.

After Hours: Drs Vaughn and Kory Breaking New Ground on Covid and Covid Vaccine Injuries (Podcast) Read More »

Scroll to Top